NEOCIDE-3
Live / Registered — Registered and renewed (as of 22 Mar 2022)
What this means for you
Registered since 08 Nov 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Nov 2021).
Record
- Serial number
- 85273331
- Registration number
- 4052461
- Mark type
- Stylized text
- Filed
- 22 Mar 2011
- Published for opposition
- 23 Aug 2011
- Registered
- 08 Nov 2011
- Next maintenance due
- 08 Nov 2021
Goods and services
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals for veterinary use; Antibacterial substances for veterinary use; Dermatological pharmaceutical products for veterinary use; Pharmaceutical preparations and substances for veterinary use for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for veterinary use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for veterinary use for the treatment of infectious diseases; Pharmaceutical preparations for veterinary use for the treatment of skin lesions; Pharmaceutical preparations for veterinary use in dermatology; Pharmaceutical preparations for veterinary use for wounds; Pharmaceuticals, namely, anti-infectives for veterinary use; Therapeutic pharmaceutical for veterinary use for the treatment of skin lesions
Owner
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
- Molecular Therapeutics, Athens, GA, US
Prosecution history
- 22 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Mar 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 22 Mar 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Nov 2021 — TEAS SECTION 8 & 9 RECEIVED
- 08 Nov 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Apr 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Nov 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 01 Aug 2018 — POST REGISTRATION ACTION MAILED - SEC. 8
- 25 Jul 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Apr 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 06 Sept 2017 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 09 Aug 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Jun 2017 — TEAS SECTION 8 & 15 RECEIVED